Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants

Abroad (travel likely)RecruitingPHASE1

Conditions

Overweight and/or Obesity

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Celerion Clinical Research, Tempe, Arizona, United States
Contact: Study coordinator (Jacob Landolt) · jacob.landolt@celerion.com · 1-866-445-7033
Contact: Principal Investigator (Bridgette Blazek, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or Obesity

Obesity · Overweight

Abroad (travel likely)RecruitingPHASE1

Berlin, Germany

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Overweight · Obesity

IsraelRecruitingPHASE3

Escondido, United States · Hollywood, United States

Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)

Overweight · Overweight and Obesity · Overweight or Obesity

Abroad (travel likely)RecruitingPHASE2

New York, United States

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

Metabolic Disease · Obesity · Li-Fraumeni Syndrome

Abroad (travel likely)Recruiting

Washington D.C., United States · Bethesda, United States